Dendritic cell progenitors engineered to express extracellular-vesicle–internalizing receptors enhance cancer immunotherapy in mouse models

Journal:

Nature Communications

Published:

2025-10-15

DOI:

10.1038/s41467-025-64172-w

Affiliations:

9

Authors:

13

Go to article

Institutions	Authors	Share
Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland	3.666667	0.28
AGORA Cancer Research Center, Switzerland	2.916667	0.22
Swiss Cancer Center Léman (SCCL), Switzerland	2.916667	0.22
Netherlands Cancer Institute (NKI), Netherlands	2.000000	0.15
University of Lausanne (UNIL), Switzerland	0.500000	0.04
University Hospital of Lausanne (CHUV), UNIL, Switzerland	0.500000	0.04
Geneva University Hospitals (HUG), Switzerland	0.250000	0.02
University of Geneva (UNIGE), Switzerland	0.250000	0.02

Interested in Immunology?